ARCHIVES

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

This article is from The Cancer Letter archive.

Vol. 20 No. 12 | March 23, 1994

Download PDF Visit The Full Archive

Related Articles

Final Issue Of 1992

December 11, 1992

FDA, NIH Streamline Approvals For Gene Therapy Studies

June 16, 1995

ASCO honors physicians for clinical trials participation.

June 4, 2004

CAP, ASCCP Recommendations Standardize Lesion Terminology

July 27, 2012

Tarceva-Induced Rash Strongly Associated With Longer Survival, Sponsor Finds

July 27, 2007

ORI Final Findings Of Scientific Misconduct

September 16, 1994